NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
about
Multiple system atrophy: cellular and molecular pathology.Multiple system atrophy: a clinical and neuropathological perspectiveGlia and alpha-synuclein in neurodegeneration: A complex interactionSerotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseAlpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channelWidespread alterations of alpha-synuclein in multiple system atrophyThe solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Alpha-synuclein in Lewy body disease and Alzheimer's disease.Multiple system atrophy: a sporadic synucleinopathy.Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasiaNeuropathology of synuclein aggregates.Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.Late-onset neurodegenerative diseases--the role of protein insolubility.The pathogenesis of multiple system atrophy: past, present, and future.Encephalomyelitis, brain tumors, neuromuscular diseases and miscellaneous disorders.β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.Relocation of p25α/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.The cellular pathology of Parkinson's disease.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesNeuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.Iron in neurodegenerative disorders.SIRT1 protects against α-synuclein aggregation by activating molecular chaperonesNon-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesPropagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged MacaquesCellular pathology in multiple system atrophy.Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.Multiple system atrophy: alpha-synuclein and neuronal degeneration.The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophyDual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding ProteinsNeuropathology underlying clinical variability in patients with synucleinopathies.The Lewy body in Parkinson's disease and related neurodegenerative disorders.Does a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology?Multiple system atrophy of the cerebellar type: clinical state of the art.α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling.An update on the cerebellar subtype of multiple system atrophy.Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction
P2860
Q24535446-AF9ED9C3-2AB5-404D-A279-4AB7DAC92D26Q26829838-A238E8C5-36CF-417B-B88F-A244D0EB79B8Q26851153-B6132BD5-DBD5-499E-9AD2-2FA29EF083F9Q28079379-2512C843-43DC-4A0C-BD87-8A5627BE5F49Q30153436-67CAE1FA-EFB8-44AB-8C31-BBE4FECCD1F8Q30444927-C9895AED-270F-41F2-81E0-0373B02E95F3Q31807516-559103DE-ACE7-4970-BF34-141570A85669Q33703950-052895D1-FC3C-4018-8FD8-8A5E32ED5E0EQ33750063-D72F4EE4-5B92-4E55-AC03-29C9B23FBFA2Q33750069-5BDAFD8C-F0A8-4FF4-B705-6590FE451695Q33805560-D15E7D3F-C7EC-48A2-936C-8086A31D10A0Q33821143-E7B6AE79-3F1C-47DE-8727-051B7E6CE6B7Q33957376-41D55809-4CC1-4753-B92D-54066081AB00Q33958289-192E20F9-8875-4BCD-92CA-E3CA226CB6BEQ33989372-66D3070A-649E-4186-A5B7-8199D287BFBEQ34048136-34F0FF5C-1CF0-4BAF-8E6C-19CF557C627DQ34063829-A093FF42-643F-46DA-BE1E-72B2B5570302Q34107278-9C2A7456-3455-4A1F-BE1C-74A4073258CFQ34233323-828E71F9-6368-4977-BEF9-B56BD96AFCCBQ34523836-896BB217-BF00-41D6-ABD5-AF13EE2593D9Q34538330-1AD0FF78-0B84-43BD-BC04-7F8F7D9EB962Q34648491-B81E5901-967E-4A09-9DFC-8CD007620411Q35112542-699682C2-2275-4628-A65E-8F1AFBF9B6DDQ35686386-39103561-F243-4611-8F51-5FDE9E3951C5Q35788235-52A1BA6B-C8F3-467B-B42F-0100AADCC15DQ35829548-440882E0-A392-4E68-902F-7844EDDE58ECQ36197708-848FB3B1-7F3E-4197-8B47-6F7F56B8909DQ36589164-E3DD7B40-78AF-49E0-A9D2-EA564E42EC61Q36788234-F01E3370-7DDC-4453-BEF5-AF9BDD58DD6DQ37003479-75A43F62-3FBB-4E50-8842-0F83D026E0B9Q37003482-794AAA4B-5C6E-431C-AFB4-96DBC9E08DEEQ37164569-A2424F31-98EE-4C1B-9D26-799C52B3F0DEQ37401787-F62145B6-2585-4681-8923-9A26AC7AE794Q37896515-A94CB946-DBAE-41C3-B4B8-0B36D120E11BQ38012653-3383DC3E-71CC-437F-BA88-2470F095AE70Q38067885-B881BB5E-C1CE-4182-A3C0-001318DEB085Q38194974-DB76A960-27B4-4A8E-B0B5-02D0A050DD88Q38241438-D68E9A87-6900-4A88-819C-C59434B0F554Q38578814-E9EE8659-2DA7-45B4-A0EB-D867B4A5B3BBQ38923732-68C6C0CC-8DCC-4D8D-A87B-4251D4A91272
P2860
NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@ast
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@en
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@nl
type
label
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@ast
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@en
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@nl
prefLabel
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@ast
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@en
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@nl
P2093
P356
P1476
NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy
@en
P2093
H Tonozuka-Uehara
M Nakamura
N Sunohara
P2888
P304
P356
10.1007/S004010050917
P407
P577
1998-11-01T00:00:00Z
P5875
P6179
1015249478